Quantifying important risk factors and survival following treatment in people with lung cancer using routinely collected national data

QR Code

Quantifying important risk factors and survival following treatment in people with lung cancer using routinely collected national data

Background: Survival for people with lung cancer is poor and inequalities in access to care have been demonstrated. Methods: Primary care data from The Health Improvement Network, secondary care data from Hospital Episodes Statistics and the National Lung Cancer Audit, and death records from the...

Full description

Bibliographic Details
Main Author:	Powell, Helen.
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2014
Subjects:	Risk factors for lung cancer Lung cancer mortality Aetiology of lung cancer Lung cancer care
Online Access:	https://eprints.nottingham.ac.uk/14092/

Similar Items

Lung cancer diagnosed following an emergency admission: mixed methods study of the management, outcomes and needs and experiences of patients and carers
by: Wilcock, Andrew, et al.
Published: (2016)

Factors influencing the diagnosis and subsequent prognosis in patients with lung cancer
by: O'Dowd, Emma Louise
Published: (2017)

Lung cancer stage-shift following a symptom awareness campaign
by: Kennedy, Martyn, et al.
Published: (2018)

Formulation and optimization of nanoemulsion containing gemcitabine for lung cancer treatment
by: Wahgiman, Nadiatul Atiqah
Published: (2019)

Validation of the National Lung Cancer Audit database and analysis of the information it contains
by: Rich, Anna
Published: (2012)

What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?
by: O'Dowd, Emma L., et al.
Published: (2015)

Significance of subcentimetre 18F-FDG PET/CT pulmonary abnormality in patients with known extrapulmonary malignancy.
by: Ahmad Saad , Fathinul Fikri, et al.
Published: (2010)

Which patients are assessed by lung cancer nurse specialists? A national lung cancer audit study of over 128,000 patients across England
by: Khakwani, Aamir, et al.
Published: (2016)

Predicting death from surgery for lung cancer: a comparison of two scoring systems in two European countries
by: O'Dowd, Emma L., et al.
Published: (2016)

Counting the costs of cancer care: breast, cervical and lung cancer in Trent
by: Wolstenholme, Jane
Published: (2001)

OA 06.08 Is Lung Cancer Screening Associated with a Negative Psychological Impact?
by: Clark, Marcia, et al.
Published: (2017)

An investigation into treatment administration and survival for people with small cell lung cancer
by: Jones, Gavin Stewart
Published: (2019)

Within and between day repeatability of the incremental shuttle walking test in patients with thoracic cancer
by: Wilcock, Andrew, et al.
Published: (2018)

Factors influencing treatment selection and thirty-day mortality following chemotherapy for people with small cell lung cancer: an analysis of national audit data
by: Jones, Gavin S., et al.
Published: (2018)

Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients
by: Ravipati, Srinivasarao, et al.
Published: (2015)

Theranostic tools against lung and breast cancers : through the lens of mature gold nanoparticles and emerging graphene
by: Baskaran, Savuntherii, et al.
Published: (2024)

Study on Liposomes Integrity and Delivery of siRNA to Lung Cancer
by: Aljasser, Abdullah
Published: (2024)

Tissue characterisation by Raman spectroscopies
by: Bourbousson, Manon Fanny
Published: (2020)

Building an ex vivo model of breast cancer lung metastasis
by: Grey, James F.E.
Published: (2019)

Lung cancer CT screening: psychological responses in the presence and absence of pulmonary nodules
by: Clark, Marcia E., et al.
Published: (2018)

Factors surrounding treatment decisions in non-small cell lung cancer
by: Morgan, Helen
Published: (2024)

In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011
by: Hutchinson, John P., et al.
Published: (2016)

MA 18.04 Changes in smoking behavior in the Early Cancer Detection Test Lung Cancer Scotland (ECLS) Study
by: Young, Ben, et al.
Published: (2017)

Homing peptides (rgd/irgd) functionalized zeolitic imidazolate framework-8 for targeted delivery of gemcitabine to lung cancer cell
by: Mohd Abdul Kamal, Nurul Akmarina
Published: (2022)

Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data
by: Walker, Alex J., et al.
Published: (2016)

Lung cancer in United Kingdom general practice and the possibility of developing an early warning score
by: Iyen-Omofoman, Barbara
Published: (2012)

The emotional impact of screening for lung cancer
by: Bedford, Laura Elizabeth
Published: (2017)

Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
by: Hutchinson, John P., et al.
Published: (2016)

Is clarithromycin a potential treatment for cachexia in people with lung cancer?: a feasibility study
by: Awan, Sarah, et al.
Published: (2017)

Can body composition be used to optimize the dose of platinum chemotherapy in lung cancer? A feasibility study
by: Crosby, Vincent, et al.
Published: (2016)

Application of autoantibody binding curve characteristics and machine learning methods for improving the diagnostic performance of an early detection test for lung cancer
by: Allen, Jared
Published: (2023)

Docetaxel-loaded magnetic nanostructured lipid carrier functionalized with fish oil-coated iron oxide nanoparticles intended for lung cancer treatment
by: Idris, Auni Hamimi
Published: (2021)

Anti-tumour efficacy of human mesenchymal stem cell expressing trail on lung cancer cell lines-derived cancer stem cell
by: Shaik M Fakiruddin, Shaik Ahmad Kamal
Published: (2021)

P3.06-009 How does screening for the early detection of lung cancer facilitate smoking cessation?: a qualitative study of screened smokers
by: Young, Ben, et al.
Published: (2017)

Identification of differentially regulated genes in breast (MCF-7) and lung (H1299) cancer cell lines during Newcastle disease virus strain AF2240 infection
by: Roslan, Nurhidayah
Published: (2012)

Biological Evaluation of Synergistic Drug Combinations, Design and Synthesis of Potent and Selective PI3K Inhibitors and the Design of Bifunctional Ligands Incorporating Pictilisib & Ceritinib for the Treatment of EML4-ALK Positive Lung Cancer
by: Garces, Aimie E.
Published: (2019)

Adrenergic blockers and the risk for common solid cancers: a case-control study
by: Numbere, Beade, et al.
Published: (2017)

Brain metastases following radical surgical treatment of non-small cell lung cancer: is preoperative brain imaging important?
by: O'Dowd, Emma L., et al.
Published: (2014)

Facilitating early diagnosis of lung cancer amongst primary care patients: the views of GPs
by: Wagland, R., et al.
Published: (2017)

Greenly synthesised biocompatible graphene/zirconia nanocomposite: towards the development of a biosensor for the detection of lung cancer biomarkers
by: Lin, Lih Poh
Published: (2022)